Presentation is loading. Please wait.

Presentation is loading. Please wait.

Health Effects, Consumer, Indirect and Occupational Exposure in the Pb RA C. Boreiko ICF 8 – 11 October 2005.

Similar presentations


Presentation on theme: "Health Effects, Consumer, Indirect and Occupational Exposure in the Pb RA C. Boreiko ICF 8 – 11 October 2005."— Presentation transcript:

1 Health Effects, Consumer, Indirect and Occupational Exposure in the Pb RA C. Boreiko ICF 8 – 11 October 2005

2 Topics  Evaluation of the health literature  Consumer exposure scenarios for crystal  Indirect exposure (local sources)  Occupational exposure  Implications for the crystal industry

3 Health Literature  Focused upon ~1,200 key human health papers selected from more than 9,000 considered  Where possible used “consensus” documents to summarize older literature and for background information ATSDR Toxicological Profile for Lead IPCS Lead EHC  Primary emphasis on evaluating primary literature for health effects critical for Risk Characterization  Use quality scoring to support conclusions and “weight of evidence” evaluations

4 Health Issues Evaluated Heme (aenemia) Renal Neurological (adult) Fetal Development Cancer Reproduction Endocrine Excretion Blood Pressure Pb Poisoning Child Development Genotoxicity Immune Uptake Toxicokinetics

5 NOAEL’s for Different End Points Health EndpointHu StudiesNOAELExposed Population Renal system effects> 4060 μg/dLAdult, all Haematological effects> 5050 μg/dLAdult, all Reproductive effects>2745 μg/dLAdults, male Nervous system effects>14040 μg/dLAdults, all Reproductive effects>2230 μg/dLAdults, female Nervous system effects>3410 μg/dL Children Nervous system effects>1110 μg/dL Foetus (exposure during pregnancy)

6 MOS  MOS ref varies as a function of endpoint severity and scientific uncertainty  Traditional sources of uncertainty include: Animal to human extrapolation Inter-individual variability in exposure or uptake Susceptible sub-populations  Endpoints for NOAELS are subtle  Uncertainty is reduced Human data Use blood lead (eliminates exposure/uptake variability) NOAEL’s for sensitive populations are identified  Use of minimal MOS (1) in VLRA

7 Crystal Product Evaluation  Examined pattern of product use “Negligible exposure” by expert judgment if product use unlikely to yield exposure  ISO standards noted as measure of product structural integrity  Food contact items subjected to detailed analysis Typical exposure estimated Hypothetical worst case exposure constructed Exposure levels then compared to a series of exposure criteria

8 Products Evaluated  Decorative crystal objects Dermal exposure/transfer Negligible exposure assumed  Flatware Food contact item Main use with dry foods Oral exposure principle route of concern Little opportunity for lead elution Negligible exposure assumed  Both of the above are “expert judgment” evaluations that result in conclusion (ii)

9 Stemware and Decanters  Typical consumer seldom uses crystal (occasional or ceremonial use) - negligible exposure  Establish worst case exposure scenario  Compare to worst case to PTWI 25  g/kg bw/wk  Calculate potential blood lead increase Slope factors IEUBK or PBPK modeling  If less than 10% PTWI and less than 1  g/dL increase in blood lead then exposure is low

10 Reasonable Worst Case Scenario  Assume all beverages consumed using crystal products  Pb in beverage values provided by ICF from recent lead elution studies  Couple this to (ICF provided) data on beverage consumption in the EU  Combine the two to generate an estimate of lead intake from crystal stemware and decanter use for short-term storage

11 Sample calculations - Stemware  First time use of crystal stemware can yield 100 – 200  g/L Pb.  200 ml serving size yields up to 40  g Pb intake  Single serving would not elevate blood lead  Chronic intake at this level could be of concern but  Pb elution attenuates with stemware use (15  g/L)  Chronic oral intake assumed to be associated with lower elution level  Index to average per capita intake of spirits, wine, mineral water etc., 6  g/day ingestion

12 RWC for Crystalware ProductRouteRWC  PbB % PTWI StemwareOral 6  g/d 0.5 (PBPK) 0.3 (SF) 2.4% Decanter (short-term) Oral 2  g/d 0.17 (PBPK) 0.1 (SF) 0.8% Decanter (long-term)* Oral??? * Awaiting new ICF data. Literature values of > 1 mg/L could be a problem

13 Stemware/Decanter Conclusions  Exact numbers can be challenged, but estimates are far below “screening criteria” for products  Conclusion (ii) proposed for stemware and short- term decanter use  Long-term decanter use unresolved and awaiting industry data  Likely to the the product application of greatest concern – and the most difficult to model  High accumulation if not consumed, but if not consumed where is the exposure?  Probabilistic modeling may be required

14 Local Exposures  Screened emissions for air lead levels or soil lead (current contribution) that would increase PbB by 1  g/dL or more  Facilities that did not pass this “screen” subjected to more detailed evaluation  All crystal facilities had low predicted additions to soil (<30 ppm)  All less than 500 ng/m 3 air screening  All are concluded to be conclusion (ii) or no risk

15 Conclusions – Lead Crystal Production I Coverage“OK” (on-going) Representative natureYes Inhalation exposure adequate?Yes (borderline) Dermal exposure adequate?Yes (published data) Blood lead data adequate?Yes RPE analysis completed?Not conducted

16 Lead crystal glass production blood leads bar: median, cross: arithmetic mean, box: inter-quartile-range, whiskers: 90th and 10th percentile

17 Conclusions – Lead crystal glass production II Typical blood lead values are all well below 40 µg/dL, and only the 90th percentile for the workplace category raw material handling (B1) exceeds the threshold of 40 µg/dL. Conclusion for male workers only – no data to assess presence of women of reproductive capacity workplace category job description worst case [90 th perc.] typical [median] no. of data risk conclusion B1raw material handling 4626286 (iii) B2forming processes 35181,690 (ii) B3cutting processes 36211,006 (ii) B4polishing processes 3116176 (ii) B5others 28151,237 (ii)

18 Conclusions for Crystal  Most crystal products pose little exposure risk (conclusion ii) – but careful scrutiny expected from some MS  Long-term storage in decanters an issue to be resolved  Local source issues do not appear to a problem  Occupational exposures for males is conclusion (ii) except for raw material handling  Issue of 10  g/dL limit for women may change this picture  Rejection of MOS ref = 1 would create problems


Download ppt "Health Effects, Consumer, Indirect and Occupational Exposure in the Pb RA C. Boreiko ICF 8 – 11 October 2005."

Similar presentations


Ads by Google